Application Sponsors
Marketing Status
Application Products
001 | SOLUTION;INTRAVENOUS | EQ 30MG BASE/3ML (EQ 10MG BASE/ML) | 0 | CAFFEINE CITRATE | CAFFEINE CITRATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2017-12-14 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2020-11-12 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2020-11-12 | STANDARD |
LABELING; Labeling | SUPPL | 5 | AP | 2020-11-12 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 15 |
SUPPL | 3 | Null | 7 |
SUPPL | 4 | Null | 7 |
SUPPL | 5 | Null | 7 |
TE Codes
CDER Filings
MICRO LABS
cder:Array
(
[0] => Array
(
[ApplNo] => 207400
[companyName] => MICRO LABS
[docInserts] => ["",""]
[products] => [{"drugName":"CAFFEINE CITRATE","activeIngredients":"CAFFEINE CITRATE","strength":"EQ 30MG BASE\/3ML (EQ 10MG BASE\/ML)","dosageForm":"SOLUTION;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"12\/14\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2017-12-14
)
)